Product
IBI319
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
An Open-label, Multicenter, Phase Ia/Ib Study to Evaluate the Safety, Tolerance and Preliminary Efficacy of IBI319 in Patients With Advanced Malignant TumorsStatus: Active (not recruiting), Estimated PCD: 2022-12-21